The palliative treatment of non-small cell lung cancer is very importa
nt from a public health standpoint due to the large number of patients
who die each year from this disease. Radiation therapy (RT) is an eff
ective modality for the treatment of symptomatic primary intrathoracic
disease as well as metastases to the bone and brain. The optimal RT d
ose schedules have not been clearly established, but the majority of p
atients will enjoy good symptom relief with acceptably low toxicity fr
om doses in the range of 30 Gy delivered in 10 fractions.